Alpha Teknova, Inc. (NASDAQ:TKNO) Shares Bought by Tradewinds LLC.

Tradewinds LLC. raised its position in Alpha Teknova, Inc. (NASDAQ:TKNO) by 205.6% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 133,088 shares of the company’s stock after acquiring an additional 89,538 shares during the quarter. Tradewinds LLC.’s holdings in Alpha Teknova were worth $691,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of TKNO. NewEdge Advisors LLC boosted its position in shares of Alpha Teknova by 14.3% during the 4th quarter. NewEdge Advisors LLC now owns 15,632 shares of the company’s stock worth $131,000 after purchasing an additional 1,953 shares in the last quarter. Squarepoint Ops LLC boosted its position in shares of Alpha Teknova by 8.4% during the 4th quarter. Squarepoint Ops LLC now owns 30,985 shares of the company’s stock worth $259,000 after purchasing an additional 2,388 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Alpha Teknova by 622.5% during the 4th quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company’s stock worth $37,000 after purchasing an additional 3,791 shares in the last quarter. Bank of America Corp DE boosted its position in shares of Alpha Teknova by 1.8% during the 4th quarter. Bank of America Corp DE now owns 221,285 shares of the company’s stock worth $1,848,000 after purchasing an additional 3,904 shares in the last quarter. Finally, Two Sigma Investments LP boosted its position in shares of Alpha Teknova by 46.2% during the 4th quarter. Two Sigma Investments LP now owns 15,148 shares of the company’s stock worth $126,000 after purchasing an additional 4,789 shares in the last quarter. 13.81% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Alpha Teknova

In related news, Director Martha J. Demski sold 8,000 shares of the business’s stock in a transaction dated Friday, June 27th. The shares were sold at an average price of $5.06, for a total value of $40,480.00. Following the sale, the director directly owned 12,000 shares in the company, valued at $60,720. The trade was a 40.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 12.50% of the stock is owned by corporate insiders.

Alpha Teknova Price Performance

Shares of NASDAQ TKNO opened at $5.22 on Friday. The firm has a market capitalization of $278.96 million, a P/E ratio of -10.87 and a beta of 0.33. Alpha Teknova, Inc. has a one year low of $1.16 and a one year high of $10.37. The company’s fifty day moving average is $5.92 and its two-hundred day moving average is $6.70. The company has a debt-to-equity ratio of 0.17, a quick ratio of 4.71 and a current ratio of 5.64.

Alpha Teknova (NASDAQ:TKNO) last released its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.02. Alpha Teknova had a negative net margin of 60.90% and a negative return on equity of 28.48%. The business had revenue of $9.60 million for the quarter, compared to analyst estimates of $9.41 million. Analysts forecast that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.